Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of the American College of Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(97)00423-3PMID 9426014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Syndromes of Accelerated Atherosclerosis

  1999cited by this paper
• Role of angiographically identifiable thrombus on long-term luminal renarrowing after coronary angioplasty: a quantitative angiographic analysis.

  1996cited by this paper
• Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool.

  1996cited by this paper
• Coronary angioscopy of abrupt occlusion after angioplasty.

  1995cited by this paper
• Prevention of cardiovascular ischemic complications with new platelet glycoprotein IIb/IIIa inhibitors.

  1995cited by this paper
• Angioscopic versus angiographic detection of thrombus during coronary interventional procedures.

  1995cited by this paper
• Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects: comparison to angiography.

  1994cited by this paper
• Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus.

  1994cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.

  1994cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

  1994cited by this paper
• Coronary arteries in unstable angina pectoris, acute myocardial infarction, and sudden coronary death.

  1994cited by this paper
• Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

  1994cited by this paper
• Serial angioscopic and angiographic observations during the first hour after successful coronary angioplasty: a preamble to a multicenter trial addressing angioscopic markers for restenosis.

  1994cited by this paper
• Angioscopy, coronary thrombi and acute coronary syndromes.

  1993cited by this paper
• Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile.

  1992cited by this paper
• Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty.

  1992cited by this paper
• Quantitative Angiographic Morphology of the Coronary Artery Lesions at Risk of Thrombotic Occlusion

  1992cited by this paper
• Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis.

  1991cited by this paper
• Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction.

  1991cited by this paper
• The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty.

  1991cited by this paper
• Restenosis after coronary angioplasty: an overview.

  1991cited by this paper
• A Monoclonal Antibody Against the Platelet Glycoprotein IIb/IIIa Receptor Complex Prevents Platelet Aggregation and Thrombosis in a Canine Model of Coronary Angioplasty

  1991cited by this paper
• Acute Coronary Artery Occlusion During and After Percutaneous Transluminal Coronary Angioplasty: Frequency, Prediction, Clinical Course, Management, and Follow‐up

  1991cited by this paper
• Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation.

  1990cited by this paper
• Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus.

  1990cited by this paper
• Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.

  1990cited by this paper
• Management of complicated coronary angioplasty by intracoronary urokinase and immediate re-angioplasty.

  1990cited by this paper
• Percutaneous transluminal coronary angioplasty in the setting of large intracoronary thrombi.

  1990cited by this paper
• Angiographic observations and clinical relevance of coronary thrombus in unstable angina pectoris.

  1989cited by this paper
• Role of intracoronary thrombus in acute complications during percutaneous transluminal coronary angioplasty.

  1989cited by this paper
• Restenosis After Coronary Angioplasty: Potential Biologic Determinants and Role of Intimal Hyperplasia

  1989cited by this paper
• Restenosis after successful coronary angioplasty. Pathophysiology and prevention.

  1988cited by this paper
• Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.

  1988cited by this paper
• Percutaneous transluminal coronary angioplasty in patients with intracoronary thrombus.

  1988cited by this paper
• Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.

  1988cited by this paper
• Restenosis after arterial angioplasty: a hemorrheologic response to injury.

  1987cited by this paper
• Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: improving results.

  1986cited by this paper
• Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty.

  1985cited by this paper
• A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

  1983cited by this paper

• Atherosclerotic Plaque Component as a Risk Factor for Distal Embolization During Percutaneous Coronary Intervention　- Pathology of Tissue Obtained by Distal Protection Device.

  2018cites this paper
• Adjunctive Pharmacotherapy for Thrombotic Coronary Lesions.

  2013cites this paper
• Arterial Wall Remodeling and Restenosis Following Vascular Reconstruction

  2013cites this paper
• Antiplatelet agents for chronic kidney disease.

  2013cites this paper
• 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c

  2011cites this paper
• 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• Practice Guidelines College of Cardiology Foundation/American Heart Association Task Force on Angina/Non ST-Elevation Myocardial Infarction: A Report of the American Guidelines for the Management of Patients With Unstable 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007

  2011cites this paper
• Angina/Non ACC/AHA 2007 Guidelines for the Management of Patients With Unstable

  2011cites this paper
• Role of AngioJet rheolytic thrombectomy catheter: Mount Sinai Hospital experience.

  2010cites this paper
• Rheolytic thrombectomy in patients with acute coronary syndrome and large thrombus burden: initial and mid-term results from a single centre experience.

  2010cites this paper
• Percutaneous coronary intervention in native vessels with angiographically visible thrombus temporal trends and impact of drug-eluting stents.

  2010cites this paper
• [Application of the system for rheolytic thrombectomy in patients with acute myocardial infarction].

  2008cites this paper
• The effect of thrombectomy on myocardial blush in primary angioplasty: The randomized evaluation of thrombus aspiration by two thrombectomy devices in acute myocardial infarction (RETAMI) trial

  2008cites this paper
• La trombectomia nell'angioplastica primaria

  2008cites this paper
• Distal protection device protects microvascular integrity during primary percutaneous intervention in acute myocardial infarction: a prospective, randomized, multicenter trial.

  2008cites this paper
• ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie

  2007cites this paper
• Comparison of the in vitro performance of 6 and 7 French aspiration catheters.

  2007cites this paper
• Mechanical thrombectomy options in complex percutaneous coronary interventions

  2006cites this paper
• [Does intracoronary abciximab improve the outcome of percutaneous coronary interventions? A randomized controlled trial].

  2006cites this paper
• ¿Mejora el uso de abciximab intracoronario el resultado del intervencionismo percutáneo? Estudio prospectivo y aleatorizado

  2006cites this paper
• [Coronary ectasia resulting in thrombotic coronary occlusion after warfarin interruption: a case report].

  2005cites this paper
• Feasibility and safety of thrombectomy with TVAC aspiration catheter system for patients with acute myocardial infarction

  2005cites this paper
• Distal Protection Improved Reperfusion and Reduced Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Who Had Angioscopically Defined Ruptured Plaque

  2005cites this paper
• Trombektomia w ostrym zawale serca przy użyciu systemu DIVER - opis dwóch przypadków

  2005cites this paper
• Manual thrombosuction in patients with acute myocardial infarction receiving primary coronary interventions--two case reports.

  2005cites this paper
• Early and Late Angiographic and Clinical Outcome Following Helistent Stent Implantation A Single Center Experience

  2004cites this paper
• The Use of Membrane-Covered Stent Grafts in Thrombus-Containing Coronary Vessel Lesions

  2004cites this paper
• Early and late angiographic and clinical outcome following helistent stent implantation.

  2004cites this paper
• [Rheolytic thrombectomy with AngioJet catheter during transluminal coronary revascularization in patients with acute myocardial infarction].

  2003cites this paper
• A comparative study of rotational atherectomy in acute and stable coronary syndromes in the modern era.

  2003cites this paper
• Preliminary experiences using X‐sizer catheter for mechanical thrombectomy of thrombus‐containing lesions during acute coronary syndromes

  2003cites this paper
• The long-term clinical outcomes after rescue percutaneous coronary intervention in patients with acute myocardial infarction.

  2003cites this paper
• Differential effect of aspirin on platelet aggregation in patients with coronary artery disease in relation with associated risk factors.

  2003cites this paper
• El abciximab mejora el pronóstico de los diabéticos tras la intervención coronaria percutánea

  2002cites this paper
• Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina.

  2002cites this paper
• [Does abciximab improve the prognosis of diabetics after percutaneous coronary intervention?].

  2002cites this paper
• Thrombo‐atherectomy: Hope for pesky thrombus‐containing lesions?

  2002cites this paper
• Percutaneous transluminal therapeutic ultrasound for high‐risk thrombus‐containing lesions in native coronary arteries

  2002cites this paper
• AngioJet thrombectomy and stenting for reperfusion in acute MI complicated with cardiogenic shock

  2002cites this paper
• Effectiveness of rheolytic coronary thrombectomy with the AngioJet catheter.

  2002cites this paper
• Angiographic outcome after intracoronary X‐Sizer helical atherectomy and thrombectomy: First use in humans

  2002cites this paper
• Rheolytic thrombectomy with Angiojet in thrombus‐containing lesions

  2002cites this paper
• Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An Angiographic Trials Pool data experience.

  2001cites this paper
• Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter.

  2001cites this paper
• Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience).

  2001cites this paper
• Catheter‐Delivered Ultrasound Therapy for Native Coronary Arterial Thrombosis and Occluded Saphenous Vein Grafts

  2001cites this paper
• Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.

  2000cites this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

  2000cites this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)

  2000cites this paper
• A Risk-Benefit Assessment of Abciximab in Angioplasty

  1999cites this paper
• Angiographic findings in patients with refractory unstable angina according to troponin T status.

  1999cites this paper
• Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina.

  1999cites this paper
• Point - Counterpoint: The wide use of IIb/IIIa inhibitors in interventional cardiology - is it justified?

  1999cites this paper
• GP IIb/IIIa Antagonists

  1999cites this paper
• [Acute complications of coronary angioplasty: prevention and management].

  1999cites this paper
• The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions.

  1999cites this paper
• Antiplatelet therapy for treatment of acute coronary syndromes.

  1999cites this paper
• Safety and efficacy of treatment with platelet GPIIb/IIIa receptor blockade in unstable angina patients awaiting PTCA at a referring clinic.

  1999cites this paper
• Intracoronary thrombus: an ongoing challenge.

  1999cites this paper
• Rheolytic thrombectomy with the Possis AngioJet: technical considerations and initial clinical experience.

  1999cites this paper
• AbciximabReview of its Use in Ischaemic Heart Disease

  1998cites this paper
• Abciximab

  1998cites this paper
• Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block

  1998cites this paper